America's health is at risk. Doctors do not have access to the complete safety and efficacy data for the treatments we rely on. Pharmaceutical companies control and hide information from clinical trials, preventing healthcare professionals from making the most informed decisions to get the most out of their patients.
Newly confirmed Secretary of the Department of Health and Human Services, Robert F. Kennedy Jr., can act quickly as a part of him. Prioritization “Radical Transparency” to help him mission “Make America healthy again.”
To get the drugs in the market, the Food and Drug Administration (FDA) must determine that it is safe and effective for at least one particular use and patient population. Pharmaceutical companies sponsor and fund clinical trials to test products, and the FDA analyzes the results when making an approval decision.
However, pharmaceutical companies Own the data From their exams, it means that no one other than the FDA will be able to see the full results. Medical Journal – Gold Standards for Medical Knowledge for Doctors – Publishes an article explaining the results of drug tests. However, the manuscripts examined by peer reviewers Include only limited, selected summary information Not complete data. Therefore, clinical trial results published in peer-reviewed medical journals have not been genuinely examined.
This lack of transparency gives us an incredible power over doctors, patients and even government decisions, encouraging them to control the information they see.
From 1999 to 2014, pharmaceutical company Roche was raked for $18 billion Worldwide From Tamiflu, drugs prevent And influenza offers minimal benefits and treats despite it causing adverse reactions like vomiting. Roche was successful based on hiding The results of their sponsored exams Promotion From the American Medical Association's journal JAMA Internal Medicine. After years of Cochrane collaboration investigators hugged Roche to the hound, they had access to the test data. Expose Scam of 2014.
In the early 2000s, Estimated 40,000-60,000 Americans have died from the anti-inflammatory drug Vioxx after drug company Merck concealed serious cardiovascular adverse events such as heart attacks and strokes. different Published Articles in the New England Journal of Medicine did not reveal or underestimate the risks of Vioxx. Merck I've reported it More serious cardiovascular risks to FDA. Fortunately, independent investigators like Dr. Jennifer Hachebeck and John Abramson We were able to find a contradiction in the published FDA review document. However, this case reveals the dangerous consequences of low transparency.
Mostly people to access complete trial data file The Freedom of Information Act requires the FDA. These requests are inherently reactive, and investigators have to petition, wait for a long time and spend a lot of money. For example, FDA I tried We determine that it will take 75 years for the data to be released to punt requests to release clinical trial information for Pfizer's covid vaccine. Ultimately, the judge forced the agency to begin publishing the data in 2022.
The results were better than many FOIA requests. The FDA has it historically side The industry can keep clinical trial data locked in. FOIA Exemption 4 I'll allow it An agency that protects commercially sensitive information and trade secrets. The FDA has consistently accepted industry objections to its request to release clinical trial information under Exemption 4. The Supreme Court has Domination That FOIA exemption is optional and does not interfere with disclosure.
Kennedy was able to instruct the FDA to increase transparency by simply releasing more trial data requested under the FOIA, but he can go further. He's full authority Prospectively release clinical trial data for medical products (identified to protect the privacy of trial participants) upon FDA approval, and retrospectively release clinical trial data from previously approved products.
The Supreme Court upheld that Federal Housekeeping Actfederal agencies may disclose “records, papers, property” unless they violate other laws that expressly prohibit certain disclosures, such as the Trade Secret Act. Clinical trial data that provides complete results demonstrate safety and efficacy, and reveals I'll do it do not have It constitutes a trade secret. In fact, the council Instructions Ministry of Health and Welfare to increase drug data transparency under the Food and Drug Administration Amendment Act of 2007.
His confirmation hearing, Kennedy Discussed “His desire to bring public health agencies to gold standards within his scope, through ensuring that all science is published in raw data. It is important to ensure that medical decisions are notified by correct information: only the US explains 60 In 80 The proportion of global spending on drugs. Americans are taking more and more more Medicines and the country is suffering Much worse Health results compared to fellow countries.
By releasing clinical trial data upon approval, Kennedy can provide physicians and medical professionals with the information they need to truly determine whether a drug is safe, effective and affordable compared to alternative treatments. According to the survey, pharmaceutical companies Don't spend The most common advertising drugs that actually offer the most medical benefits, drug makers have a history of payments. Billions Fines for fraudulent behavior. As head of HHS, Kennedy can use existing powers to enhance transparency, protect patients, and help “make America healthy again.”
Brandon Novick is a national program outreach assistant at the Center for Economic Policy Research, conducts health policy research and educates federal policymakers on issues such as Medicare, healthcare private equity, and industry management of medical research.
